Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Russell-Jones

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
The British Journal of Dermatology|September 1, 1999
Seizures associated with interferon-alpha treatment of cutaneous malignanciesM Ameen, R Russell-Jones
Seminars in Cutaneous Medicine and Surgery|July 13, 2000
Sézary syndrome: diagnostic criteria and therapeutic optionsR Russell-Jones, S Whittaker
Clinical and Experimental Dermatology|July 13, 2004
Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophiliaS Shankar, R Russell-Jones
The British Journal of Dermatology|February 17, 1999
Chronic endemic hydroarsenicismA Woollons, R Russell-Jones
Clinical and Experimental Dermatology|May 8, 1999
Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicityC G Aplin, R Russell-Jones
The British Journal of Dermatology|November 1, 1995
Terbinafine and fixed drug eruptionS E Munn, R Russell Jones
Bailliere'S Clinical Haematology|December 1, 1996
Management of cutaneous lymphomaR Russell-Jones, M F Spittle
Lancet (London, England)|November 24, 1979
Isoniazid-induced pellagra despite vitamin-B6 supplementationD A Bender, R Russell-Jones
The American Journal of Dermatopathology|October 28, 1998
The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomasT Basarab, G Orchard, R Russell-Jones
Histopathology|June 1, 1993
Pustular drug eruptions: a histopathological spectrumN P Burrows, R R Russell Jones
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
The British Journal of Dermatology|September 1, 1999
Seizures associated with interferon-alpha treatment of cutaneous malignanciesM Ameen, R Russell-Jones
Seminars in Cutaneous Medicine and Surgery|July 13, 2000
Sézary syndrome: diagnostic criteria and therapeutic optionsR Russell-Jones, S Whittaker
Clinical and Experimental Dermatology|July 13, 2004
Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophiliaS Shankar, R Russell-Jones
The British Journal of Dermatology|February 17, 1999
Chronic endemic hydroarsenicismA Woollons, R Russell-Jones
Clinical and Experimental Dermatology|May 8, 1999
Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicityC G Aplin, R Russell-Jones
The British Journal of Dermatology|November 1, 1995
Terbinafine and fixed drug eruptionS E Munn, R Russell Jones
Bailliere'S Clinical Haematology|December 1, 1996
Management of cutaneous lymphomaR Russell-Jones, M F Spittle
Lancet (London, England)|November 24, 1979
Isoniazid-induced pellagra despite vitamin-B6 supplementationD A Bender, R Russell-Jones
The American Journal of Dermatopathology|October 28, 1998
The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomasT Basarab, G Orchard, R Russell-Jones
Histopathology|June 1, 1993
Pustular drug eruptions: a histopathological spectrumN P Burrows, R R Russell Jones
Pageof 14